Page last updated: 2024-12-06
n-methyl-7h-dibenzo(c,g)carbazole
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N-methyl-7H-dibenzo(c,g)carbazole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 33699 |
| SCHEMBL ID | 10023491 |
| MeSH ID | M0122178 |
Synonyms (19)
| Synonym |
|---|
| 7h-dibenzo(c,g)carbazole, n-methyl- |
| brn 0238629 |
| n-methyl-3:4:5:6-dibenzcarbazole |
| n-methyldibenzo(c,g)carbazole |
| n-methyl-7h-dibenzo(c,g)carbazole |
| ccris 1846 |
| 27093-62-5 |
| 7-methyldibenzo(c,g)carbazole |
| unii-cw2lr35yb3 |
| 5-20-08-00622 (beilstein handbook reference) |
| cw2lr35yb3 , |
| SCHEMBL10023491 |
| DTXSID70181557 |
| n-methyldibenzo[c,g]carbazole |
| Q26840997 |
| 7-methyl-7h-dibenzo[c,g]carbazole |
| 7-methyl-7h-dibenzo(c,g)carbazole |
| n7-methyldibenzo(c,g)carbazole |
| 12-methyl-12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaene |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| " Photoactivation-induced conversion of harmless chemical compounds to toxic photoproducts associated with reactive oxygen species generation may substantially amplify the adverse health effects of UVA radiation and contribute to increased incidence of skin cancer." | ( Ultraviolet A radiation potentiates the cytotoxic and genotoxic effects of 7 H-dibenzo[c,g]carbazole and its methyl derivatives. Bábelová, A; Frecer, V; Gábelová, A; Kozics, K; Sedlačková, E; Šelc, M; Srančíková, A, 2015) | 0.42 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.43
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.43) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||